Some insurers require patients and oncologists to use drugs delivered by their preferred third-party pharmacies (also referred to as specialty pharmacies) or make patients face higher out-of-pocket costs. This is called “white” or “brown” bagging, depending on how it is mandated, and these policies interfere with oncologists’ ability to treat patients safely, which may put them at greater risk of medical challenges. COA strongly opposes white and brown bagging policies. Oncologists—not insurers—should be making treatment decisions on behalf of their patients. 

Read the entire October 2020 News Bulletin here.